OBJECTIVE: The aim of this study was to determine the effect of maternal body mass index on the incidence of neonatal prematurity morbidities in those who receive corticosteroids. STUDY DESIGN: This was a secondary analysis of a trial of corticosteroids in women at risk for preterm birth. Women receiving a single course of corticosteroids were classified by their prepregnancy body mass index (<25 and > or = 25) and compared on a composite outcome comprised of several neonatal morbidities and on each individual outcome. RESULTS: Of 183 eligible women, 96 (52.5%) had a body mass index of <25 and 87 (47.5%) had a body mass index of > or = 25. The composite outcome occurred more frequently in the body mass index of > or = 2 5 group (28.7%), compared with those with a body mass index of <25 (18.8%), although this was not statistically significant (odds ratio, 1.75; 95% confidence interval, 0.83-3.72). Body mass index was not associated with outcomes after adjusting for confounding. CONCLUSION:Maternal body mass index did not affect neonatal prematurity morbidities in those receiving corticosteroids. Copyright 2010 Mosby, Inc. All rights reserved.
RCT Entities:
OBJECTIVE: The aim of this study was to determine the effect of maternal body mass index on the incidence of neonatal prematurity morbidities in those who receive corticosteroids. STUDY DESIGN: This was a secondary analysis of a trial of corticosteroids in women at risk for preterm birth. Women receiving a single course of corticosteroids were classified by their prepregnancy body mass index (<25 and > or = 25) and compared on a composite outcome comprised of several neonatal morbidities and on each individual outcome. RESULTS: Of 183 eligible women, 96 (52.5%) had a body mass index of <25 and 87 (47.5%) had a body mass index of > or = 25. The composite outcome occurred more frequently in the body mass index of > or = 2 5 group (28.7%), compared with those with a body mass index of <25 (18.8%), although this was not statistically significant (odds ratio, 1.75; 95% confidence interval, 0.83-3.72). Body mass index was not associated with outcomes after adjusting for confounding. CONCLUSION: Maternal body mass index did not affect neonatal prematurity morbidities in those receiving corticosteroids. Copyright 2010 Mosby, Inc. All rights reserved.
Authors: Gordon C S Smith; Imran Shah; Jill P Pell; Jennifer A Crossley; Richard Dobbie Journal: Am J Public Health Date: 2006-11-30 Impact factor: 9.308
Authors: Ronald J Wapner; Yoram Sorokin; Elizabeth A Thom; Francee Johnson; Donald J Dudley; Catherine Y Spong; Alan M Peaceman; Kenneth J Leveno; Margaret Harper; Steve N Caritis; Menachem Miodovnik; Brian Mercer; John M Thorp; Atef Moawad; Mary Jo O'Sullivan; Susan Ramin; Marshall W Carpenter; Dwight J Rouse; Baha Sibai; Steven G Gabbe Journal: Am J Obstet Gynecol Date: 2006-07-17 Impact factor: 8.661
Authors: Carina C W Chan; Ernest H Y Ng; Maureen M Y Chan; Oi Shan Tang; Estella Y L Lau; William S B Yeung; Pak-Chung Ho Journal: Hum Reprod Date: 2003-11 Impact factor: 6.918